Benefits
Stress-Related Eating Support
Ashwagandha extracts standardized for high withanolide content have been studied for support of perceived stress, food cravings and stress-related weight changes. SensorilTrim leverages this profile as part of an integrated weight-management approach.
Cortisol Balance
Sensoril ashwagandha is among the better-studied adaptogenic preparations for HPA-axis support and may help maintain cortisol within a healthy range during periods of chronic stress, which is relevant for centrally distributed body fat.
Cardiovascular Risk Factor Support
Capros amla extract has been studied for support of LDL cholesterol, oxidized LDL and inflammatory markers in overweight adults. These metabolic effects complement the ashwagandha component in a stress-and-metabolic weight-management framework.
Antioxidant Defense
Amla is one of the richest natural sources of polyphenolic antioxidants. Standardized Capros provides a polyphenol-driven antioxidant load that may help offset the oxidative stress associated with adiposity and metabolic stress.
Mechanism of action
HPA-Axis Modulation (Ashwagandha)
Withanolides from Sensoril modulate hypothalamic-pituitary-adrenal axis output and have been shown in human trials to reduce serum cortisol versus placebo in chronically stressed adults, addressing a major driver of central adiposity and stress eating.
Lipid and Inflammatory Pathway Effects (Amla)
Polyphenols and tannoids in Capros amla reduce circulating LDL cholesterol and high-sensitivity C-reactive protein and improve platelet aggregation profiles in overweight adults, contributing to overall cardiometabolic health in weight-loss programs.
Oxidative Stress Reduction
Both ashwagandha and amla extracts demonstrate antioxidant capacity in laboratory and human studies, modulating markers such as malondialdehyde and glutathione redox state that are commonly disordered in obesity.
Clinical trials
Randomized, double-blind, placebo-controlled trial of ashwagandha root extract 300 mg twice daily versus placebo for 8 weeks in 52 adults under chronic stress. Outcomes: perceived stress, food cravings, body weight, BMI, cortisol, eating behaviors.
52 chronically stressed adults, 8-week intervention.
Ashwagandha significantly reduced perceived stress, food cravings and serum cortisol versus placebo and produced modest improvements in body weight and BMI alongside improved eating behaviors and happiness scores. Tolerability was good. Supports ashwagandha's role in stress-driven weight-management formulas.
Randomized clinical trial of CAPROS (Phyllanthus emblica) 500 mg twice daily for 12 weeks in overweight or class-1 obese adults. Outcomes: LDL, HDL, total cholesterol/HDL ratio, hs-CRP and platelet aggregation.
Overweight or class-1 obese adults, 12-week intervention with 2-week washout.
Capros amla significantly lowered LDL cholesterol, total cholesterol/HDL ratio and hs-CRP and reduced ADP- and collagen-induced platelet aggregation versus baseline. Supports a cardiovascular and inflammatory rationale for amla within a metabolic weight-management blend.